the Efficacy And Safety of Tranexamic Acid in Reducing Blood Loss and Transfusion Requirements During Percutaneous Nephrolithotomy
Archives of Men's Health,
Vol. 8 No. 1 (2024),
31 July 2024
,
Page e8
https://doi.org/10.22037/amh.v8i1.47754
Abstract
Introduction: This study examines TXA as a fibrinolysis inhibitor and blood clot stabilizer to evaluate its effectiveness in improving patient outcomes, reducing blood transfusion rate, and the potential to shorten the surgery duration and hospital stay. Materials and Methods: In this prospective case-control study, 200 patients with kidney stones candidates for Percutaneous nephrolithotomy (PCNL) surgery referred to Tehran's Shohada Tajrish Hospital were selected. In this regard, 100 of them, who received tranexamic acid during the surgery, were allocated to the case group, and the other 100 who did not receive it were assigned to the control group. Statistical tests were used to compare the data between the two groups. Results: The results revealed that 200 patients with kidney stones, with a mean age of 43.38, including 126 males and 46 females, were included in the study. The frequency distribution of demographic data and clinical findings between the two case and control groups was similar (p>0.05). Tranexamic acid administration in the case group compared with the control group reduced the need for blood transfusion by 81 % and reduced the mean surgery period by 21.34 minutes. Additionally, the hemoglobin drop in the case group was significantly lower than that in the control group (P<0.05). The mean change of creatinine did not show a significant difference between the two groups (P>0.05). Conclusion: The results indicate that the prescription of tranexamic acid during PCNL surgery effectively prevents bleeding and hemoglobin drop and reduces the need for blood transfusions and surgery periods without causing specific renal complications.
- Percutaneous nephrolithotomy
- Tranexamic acid
- Bleeding
- Blood transfusion
How to Cite
References
Scales Jr CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States, Urologic Diseases in America Project. journal of European urology. 2012;62(1):160-5. doi:10.1016/j.eururo.2012.03.052.
Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. The American journal of medicine. 1995;98(1):50-9.
Hasanein P, Fazelib F. Physiological causes and treatment of kidney stones from Avecina and modern medicine points of view. Journal of Islamic and Iranian Traditional Medicine. 2015;5(4):294-.
Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Journal of Annals of emergency medicine. 2007;50(5):552-63. https://doi.org/10.1016/j.annemergmed.2007.05.015.
Mosavi bahar H, Babolhaveji H, Mani kashani KH. Evaluation of the results of renal and upper ureteral stone surgery by percutaneous stone crushing. Medical Journal of Tabriz University of Medical Sciences. 2006;29(1):103 - 9 [Persian[
Sterrett SP, Penniston KL, Wolf Jr JS, Nakada SY. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate. journal of Urology. 2008;72(2):278-81. https://doi.org/10.1016/j.urology.2008.04.003.
Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU guidelines on interventional treatment for urolithiasis. European urology. 2016;69(3):475-82.
Blair B, Huang G, Arnold D, Li R, Schlaifer A, Anderson K, et al. Reduced fluoroscopy protocol for percutaneous nephrostolithotomy: feasibility, outcomes and effects on fluoroscopy time. The Journal of urology. 2013;190(6):2112-6.
Han Y, Gao W, Wang B, Gao Z, Diao M, Zuo C, et al. Risk factor analysis for infection and bleeding after lateral decubitus percutaneous nephrolithotomy. Medicine (Baltimore). 2023;102(47):e35845.
de Jesús González-Luna A, Castellanos-López MA, Juárez-Mora MA, González-Jiménez KN, Torres-Salazar QL. Migration and section of esophageal thermometer in laparoscopic sleeve gastrectomy: Clinical case of a preventable complication. Int J Surg Case Rep. 2024;124:110399.
Kim DH, Lee J, Kim SW, Hwang SH. The Efficacy of Hypotensive Agents on Intraoperative Bleeding and Recovery Following General Anesthesia for Nasal Surgery: A Network Meta-Analysis. Clin Exp Otorhinolaryngol. 2021;14(2):200-9.
Modir H, Moshiri E, Naseri N, Faraji F, Almasi-Hashiani A. A randomized parallel design trial of the efficacy and safety of tranexamic acid, dexmedetomidine and nitroglycerin in controlling intraoperative bleeding and improving surgical field quality during septorhinoplasty under general anesthesia. Med Gas Res. 2021;11(4):131-7.
Jouybar R, Nemati M, Asmarian N. Comparison of the effects of remifentanil and dexmedetomidine on surgeon satisfaction with surgical field visualization and intraoperative bleeding during rhinoplasty. BMC Anesthesiol. 2022;22(1):24.
Kim KM, Lim HW. The uses of tranexamic acid in dermatology: a review. Int J Dermatol. 2023;62(5):589-98.
Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K. Tranexamic acid in melasma: A focused review on drug administration routes. J Cosmet Dermatol. 2023;22(4):1197-206.
Sermet M, Ozsoy MS. Effect of Tranexamic Acid on Postoperative Bleeding in Sleeve Gastrectomy: a Randomized Trial. Obes Surg. 2023;33(12):3962-70.
Hinojosa-Gonzalez DE, Flores-Villalba E, Eisner BH, Olvera-Posada D. Tranexamic acid vs placebo and its impact on bleeding, transfusions and stone-free rates in percutaneous nephrolithotomy: a systematic review and meta-analysis. Cent European J Urol. 2022;75(1):81-9.
Okazaki Y, Takada H, Okada I, Hasegawa E. Effect of Carbazochrome Sodium Sulfonate in Addition to Tranexamic Acid in Bleeding Trauma Patients. Cureus. 2022;14(2):e22018.
Mokhtari MR, Farshid S, Modresi P, Abedi F. The effects of tranexamic acid on bleeding control during and after percutaneous nephrolithotomy (PCNL): a randomized clinical trial. Urology journal. 2021;18(06):608-11.
Batagello CA, Vicentini FC, Monga M, Miller AW, Marchini GS, Torricelli FC, et al. Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double‐blinded, placebo‐controlled trial. BJU international. 2022;129(1):35-47.
Moran J, Kahan JB, Morris J, Joo PY, O'Connor MI. Tranexamic Acid Administration at Hospital Admission Decreases Transfusion Rates in Geriatric Hip Fracture Patients Undergoing Surgery. Geriatr Orthop Surg Rehabil. 2022;13:21514593221124414.
Feng D, Zhang F, Liu S, Han P, Wei W. Efficacy and safety of the tranexamic acid in reducing blood loss and transfusion requirements during percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials. Minerva Urol Nefrol. 2020;72(5):579-85.
Wang Z, He X, Bai Y, Wang J. Can tranexamic acid reduce the blood transfusion rate in patients undergoing percutaneous nephrolithotomy? A systematic review and meta-analysis. Journal of International Medical Research. 2020;48(4):0300060520917563.
Samudera IMA, Hamid ARAH, Nandana PI. Roles of tranexamic acid on bleeding in percutaneous nephrolithotomy procedure: a systematic review and meta-analysis. Urological Science. 2024;35(3):127-33.
Lee MJ, Kim JK, Tang J, Ming JM, Chua ME. The efficacy and safety of tranexamic acid in the management of perioperative bleeding after percutaneous nephrolithotomy: a systematic review and meta-analysis of comparative studies. Journal of Endourology. 2022;36(3):303-12.
Marcucci M, Duceppe E, Le Manach Y, Kearon C, Eikelboom JW, Pohl K, et al. Tranexamic acid and rosuvastatin in patients at risk of cardiovascular events after noncardiac surgery: a pilot of the POISE-3 randomized controlled trial. Pilot Feasibility Stud. 2020;6:104.
Bansal A, Arora A. A double-blind, placebo-controlled randomized clinical trial to evaluate the efficacy of tranexamic acid in irrigant solution on blood loss during percutaneous nephrolithotomy: a pilot study from tertiary care center of North India. World journal of urology. 2017;35:1233-40.
MacDonald M, Ilie G, Power L, Whalen S, Parker R, Skinner TA, et al. Effect of tranexamic acid on bleeding outcomes after percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials. Journal of Endourology. 2022;36(5):589-97.
Zhang Q, Xiang C, Chen X, Chen L, Chen Q, Jiang K, et al. [Application of intravenous administration of tranexamic acid combined with local use of tranexamic acid cocktail in intertrochanteric fracture fixation]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34(4):463-
Khan MY, Saeed M, Yasin B, Ameer K, Noor N. The role of Tranexamic acid in the Reduction of Bleeding in Abdominal Aortic Aneurysm Surgery. Pakistan Armed Forces Medical Journal. 2023;73(6):1679.
Zandi R, Yousefi-Hajivand E, Manafi-Rasi A, Sajjadi MM. Intravenous Administration of Tranexamic Acid in Patients with Pelvis or Acetabulum Fractures to Reduce Blood Loss: A Double-Blind, Randomized, Controlled Trial. Journal of Orthopedic and Spine Trauma. 2024.
Yamanouchi K, Funao H, Fujita N, Ebata S, Yagi M. Safety and Efficacy of Tranexamic Acid in Spinal Surgery: A Systematic Review and Meta-Analysis. Spine Surg Relat Res. 2024;8(3):253-66.
- Abstract Viewed: 187 times
- pdf Downloaded: 184 times